{"product_id":"cleveland-clinic-heart-failure-summit-expanding-the-frontiers-of-contemporary-team-management-2025","title":"Cleveland Clinic Heart Failure Summit Expanding the Frontiers of Contemporary Team Management 2025","description":"\u003cdiv class=\"title\"\u003e\n\u003cdiv class=\"section-heading-wrapper u-margin-l-ver\"\u003e\n\u003ch3\u003eCleveland Clinic Heart Failure Summit Expanding the Frontiers of Contemporary Team Management 2025\u003c\/h3\u003e\n\u003cstrong\u003eInclude: 7 videos + 38 pdfs, size: 2.21 GB\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eTarget Audience: cardiologists, internists, primary care physicians\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eInformation:\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003eThis course provides comprehensive training for healthcare professionals in the advanced management of heart failure. The curriculum is designed to equip participants with the latest knowledge and skills necessary to optimize patient outcomes through innovative therapeutic strategies and interventions.\u003cbr\u003e\u003ch3\u003eAfter completing this course, participants will be able to\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003eApply appropriate strategies to optimize use of current and novel drug therapy of heart failure with reduced left ventricular ejection fraction\u003c\/li\u003e\n\u003cli\u003eDescribe how to utilize medical devices and surgical therapies in the care of heart failure patients\u003c\/li\u003e\n\u003cli\u003eDiscuss the clinical profile of heart failure and differentiate between reduced and preserved ejection fraction patients\u003c\/li\u003e\n\u003cli\u003eDiscuss the latest findings concerning pharmacological approaches to heart failure with midrange or preserved ejection fraction\u003c\/li\u003e\n\u003cli\u003eEmploy current therapeutic strategies for cardiac amyloid and hypertrophic cardiomyopathy\u003c\/li\u003e\n\u003cli\u003eIdentify options for electrophysiological interventions to address risk of sudden death and atrial arrhythmias in patients with heart failure\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003eWho Should Attend?\u003c\/h3\u003e\n\u003cbr\u003eThe course is directed to physicians, physician assistants, pharmacists, nurse practitioners, nurses, and all healthcare providers with an interest in treating and managing patients with heart failure.\u003cbr\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eTopics:\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eAgenda.pdf\u003cbr\u003eJune 6 Advanced evaluation of the breathless patient.pdf\u003cbr\u003eJune 6 AF ablation and the pulsed field era.pdf\u003cbr\u003eJune 6 Arrhythmogenic cardiomyopathies and genetic testing.pdf\u003cbr\u003eJune 6 Breakthroughs in obesity-related HFpEF.pdf\u003cbr\u003eJune 6 Cardiac contractility modulation.pdf\u003cbr\u003eJune 6 Current and emerging device-based therapies for HFpEF.pdf\u003cbr\u003eJune 6 Educating and engaging the patient of tomorrow.pdf\u003cbr\u003eJune 6 GDMT optimization across the inpatient-outpatient domain.pdf\u003cbr\u003eJune 6 Harnessing tech for GDMT optimization and readmission reduction.pdf\u003cbr\u003eJune 6 Harnessing the heart team for GDMT equity.pdf\u003cbr\u003eJune 6 HF STATS The changing face of heart failure.pdf\u003cbr\u003eJune 6 Lessons learnt for diverse HF trial recruitment.pdf\u003cbr\u003eJune 6 New insights into HFpEF mechanisms.pdf\u003cbr\u003eJune 6 Novel therapies for cardiomyopathies.pdf\u003cbr\u003eJune 6 Remote monitoring in the “AI era”- Leveraging new devices and algorithms.pdf\u003cbr\u003eJune 6 Remote monitoring the “old school” way- Weights, vitals and symptoms.pdf\u003cbr\u003eJune 6 Session 1 – Updates in HF Epidemiology and Population Health.mp4\u003cbr\u003eJune 6 Session 2 – HFrEF and EP Innovations.mp4\u003cbr\u003eJune 6 Session 3 – HFpEF and Pulmonary Hypertension.mp4\u003cbr\u003eJune 6 Session 4A – Meet the Clinical Trialists (Concurrent Session).mp4\u003cbr\u003eJune 6 The future of remote HF and EP monitoring.pdf\u003cbr\u003eJune 6 The LAA and controversies in anticoagulation.pdf\u003cbr\u003eJune 6 The next frontier- earlier diagnosis and treatment of HF.pdf\u003cbr\u003eJune 6 The next generation HFrEF therapies.pdf\u003cbr\u003eJune 6 Trials and tribulations in valvular interventions.pdf\u003cbr\u003eJune 6 Ventricular tachycardia in patients with HFrEF.pdf\u003cbr\u003eJune 6 What’s new in pulmonary hypertension.pdf\u003cbr\u003eJune 7 A positive PET scan- What comes next.pdf\u003cbr\u003eJune 7 Collapse to comeback- Improving outcomes after cardiac arrest.pdf\u003cbr\u003eJune 7 DanGer ahead- Seeking an evidence base for shock management.pdf\u003cbr\u003eJune 7 Evolutions in organ preservation and transportation.pdf\u003cbr\u003eJune 7 Fixing the flow- Revascularization for the high-risk patient.pdf\u003cbr\u003eJune 7 Getting shock right- Managing the right ventricle.pdf\u003cbr\u003eJune 7 HCM in the era of myosin inhibition.pdf\u003cbr\u003eJune 7 LVADs in a Transplant World.pdf\u003cbr\u003eJune 7 Managing MCS at a non-transplant center.pdf\u003cbr\u003eJune 7 Managing TTR cardiac amyloidosis in 2025.pdf\u003cbr\u003eJune 7 Multidisciplinary cardiac care during pregnancy.pdf\u003cbr\u003eJune 7 Post-heart transplant outcomes and management innovations.pdf\u003cbr\u003eJune 7 Session 1 – Cardiomyopathies (amyloid, HCM, Sarcoid) and HFrEF.mp4\u003cbr\u003eJune 7 Session 2 – MCS and TX.mp4\u003cbr\u003eJune 7 Session 3 – Cardiogenic shock and critical care.mp4\u003cbr\u003eJune 7 The next generation of LVADs and trials.pdf\u003cbr\u003eJune 7 Transplant and VAD options in congenital conditions.pdf\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954506600546,"sku":"MED-AMB04908","price":30.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/Cleveland-Heart-Failure-Summit-Expanding-the-Frontiers-of-Contemporary-Team-Management-2025-768x768-1.webp?v=1779378408","url":"https:\/\/meducourse.com\/products\/cleveland-clinic-heart-failure-summit-expanding-the-frontiers-of-contemporary-team-management-2025","provider":"Meducourse","version":"1.0","type":"link"}